Benjamin Duhart, Jr., M.S., Pharm.D.

Associate Professor
Dept of Clinical Pharmacy

Tel: (901) 448-4758


  • PostDoc, University of Tennessee Health Science Center/ Bowld Hospital; Memphis, TN, Solid organ transplantation/ immunology
  • Pharm.D., University of Tennessee, Memphis, Pharmacy
  • M.S., Florida Agricultural and Mechanical University; Tallahassee, FL, Chemistry/ Bioorganic
  • B.S., Florida Agricultural and Mechanical University; Tallahassee, FL, Chemistry

Clinical Care Specialty/Interest

Solid organ transplant/ nephrology

Research Description

My research interests include Investigating factors associated with inferior outcomes of African-American kidney transplant recipients, and evaluating renal function after liver transplantation.

Research Keywords

kidney transplant recipients


renal function

Research Interest/Specialty

Solid organ transplant/ nephrology


  1. Roe, N, Twilla, JD, Duhart, B, Wheeler, B. Breast cancer patient with everolimus-induced angioedema: A rare occurrence with potential for serious consequences. J Oncol Pharm Pract, 2016.
  2. Duhart B Jr. and Self T. Proton pump inhibitor induced kidney injury: increasing our index of suspicion.. Consultant, 56 (2016), 244, 2016.
  3. Duhart,B Jr. and Self T. Herbal-induced hepatotoxicity: increasing our index of suspicion.. Consultant, 3 (55), 202, 2015.
  4. Duhart, BT, Ally, WA, Krauss, AG, Hudson, JQ, Eason, JD, Rao, V, Vanatta, JM. The benefit of sirolimus maintenance immunosuppression and rabbit antithymocyte globulin induction in liver transplant recipients that develop acute kidney injury in the early postoperative period. J Transplant, 2015, 926168, 2014.
  5. Duhart, Jr. BT. CH 24 Solid organ transplantation., 2012.
  6. Patel, SJ, Knight, RJ, Suki, WN, Abdellatif, A, Duhart, BT, Krauss, AG, Mannan, S, Nezakatgoo, N, Osama Gaber, A. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clin Transplant, 25 (3), E250-6, 2011.
  7. Wilson NS, Duhart BT Jr., Self T. Cephalosporins: how to minimize the risk of neurotoxicity.. Consultant Live, 50 (2), 2010.
  8. Patel, SJ, Duhart, BT, Krauss, AG, Moore, LW, Egidi, MF, Amiri, HS, Gaber, LW, Gaber, AO. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction. Transplantation, 86 (2), 313-20, 2008.
  9. Duhart, BT, Honaker, MR, Shokouh-Amiri, MH, Riely, CA, Vera, SR, Taylor, SL, Al-jedai, AH, Gaber, AO. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transpl Infect Dis, 5 (3), 126-31, 2003.
  10. Ault BH, Honaker MR, Gaber AO, Jones DP, Duhart BT, Powell SL, Hays DW, Wyatt RJ. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients.. Pediatric Nephrol, 17 (10), 815, 2002.
  11. Honaker MR, Duhart BT Jr. Tacrolimus: An update on pharmacokinetic drug interactions.. J Crit Illn, 17, 141, 2002.
  12. Duhart, BT Jr., Zhang, D, Deck, J., Freeman, J.P., and Cerniglia, C.E. Biotransformation of protriptyline by filamentous fungi and yeasts. Xenobiotica, 29, 733, 1999.
  13. Zhang, D., Evans, F., Freeman, J., Duhart, Jr. BT, and Cerniglia, C.E. Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metabolism and Disposition, 23, 1417, 1995.